Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Issue of Equity

24 May 2019 18:19

RNS Number : 2026A
First Derivatives PLC
24 May 2019
Β 

24 May 2019

Β 

First Derivatives plc

("FD" or the "Company")

Β 

Issue of Equity

Β 

FD (AIM: FDP.L, Euronext Growth: FDP.I) announces that on 24 May 2019 the Company allotted 80,836 new ordinary shares of 0.5p each in the Company (the "Ordinary Shares") pursuant to the exercise of share options by certain employees.

Β 

Furthermore, on 24 May 2019 the Company allotted 35,694 ordinary shares of 0.5p each in the Company ("Ordinary Shares") in respect of the final instalment of deferred consideration relating to the acquisition of Affinity Systems Limited ('Affinity'), announced on 1 April 2015.

Β 

In addition, Non-Executive Director Virginia Gambale has been allotted 1,049 Ordinary Shares and Non-Executive Director Donna Troy has been allotted 1,199 Ordinary Shares in accordance with the terms of their engagement. The Company has also been informed by Virginia Gambale that she acquired 3,125 shares on 22 January 2018 at a price of 4,334p. As a result, Virginia Gambale holds 14,880 Ordinary Shares and Donna Troy holds 1,289 Ordinary Shares representing 0.056% and 0.005% respectively of the Company's issued share capital.

Β 

Application has been made for the new Ordinary Shares to be admitted to trading on AIM and Euronext Growth and it is expected that admission will take place on 31 May 2019. The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following these allotments, the total issued share capital of the Company will increase to 26,353,036 ordinary shares.

Β 

Enquiries

For further information please contact:

Β 

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

Β 

Β 

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 5970

Β 

Β 

Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Finbarr Griffin

+353 1 667 0420

Β 

Β 

Β 

About FD

FD is a global technology provider with more than 20 years of experience working with some of the world's largest finance, technology, retail, pharma, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 15 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.

Β 

For further information, please visit www.firstderivatives.com and www.kx.com

Β 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Β 

Name

Β 

Β 

Β Virginia Gambale

2.

Reason for the notification

a)

PositionΒ / status

Β Non-Executive Director

Β 

b)

Initial notification / amendment

Β Initial Notification

3.

Details of the Issuer

a)

Name

First Derivatives plc

b)

LEI

213800MKQAJ5R7WIU633

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Β£0.05

Β ISIN: GB0031477770Β 

b)

Nature of the transaction

Remuneration

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

2,559p

1,049

d)

Aggregated information

Β - Aggregated volume

Β - Price

N/a - single transaction

e)

Date of the transaction

24 May 2019

f)

Place of the transaction

London Stock Exchange (XLON)

Β 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Β 

Name

Β 

Β 

Β Virginia Gambale

2.

Reason for the notification

a)

PositionΒ / status

Β Non-Executive Director

Β 

b)

Initial notification / amendment

Β Initial Notification

3.

Details of the Issuer

a)

Name

First Derivatives plc

b)

LEI

213800MKQAJ5R7WIU633

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Β£0.05

Β ISIN: GB0031477770Β 

b)

Nature of the transaction

Share purchase

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

4,334p

3,125

d)

Aggregated information

Β - Aggregated volume

Β - Price

N/a - single transaction

e)

Date of the transaction

22 January 2018

f)

Place of the transaction

London Stock Exchange (XLON)

Β 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Β 

Name

Β 

Β 

Β Donna Troy

2.

Reason for the notification

a)

PositionΒ / status

Β Non-Executive Director

Β 

b)

Initial notification / amendment

Β Initial Notification

3.

Details of the Issuer

a)

Name

First Derivatives plc

b)

LEI

213800MKQAJ5R7WIU633

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Β£0.05

Β ISIN: GB0031477770Β 

b)

Nature of the transaction

Remuneration

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

2,559p

1,199

d)

Aggregated information

Β - Aggregated volume

Β - Price

N/a - single transaction

e)

Date of the transaction

24 May 2019

f)

Place of the transaction

London Stock Exchange (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
IOECKQDDOBKDAPB
Date   Source Headline
6th Jun 20177:00 amRNSEnterprise Securities Market Notice
2nd Jun 20179:56 amRNSAnnual Report 2016/17 and AGM Notice
30th May 20175:13 pmRNSDirector/PDMR Shareholding
30th May 20175:12 pmRNSDirector/PDMR Shareholding
30th May 20172:06 pmRNSIssue of Equity from exercise of Share Options
16th May 20177:00 amRNSFinal Results
15th May 20175:09 pmRNSAppointment and Directorate Change
24th Apr 20177:00 amRNSTrading Update and Notice of Results
3rd Apr 201710:28 amRNSTotal Voting Rights
20th Mar 20177:00 amRNSEnterprise Securities Market Notice
14th Mar 20174:39 pmRNSIssue of Equity
14th Mar 20177:00 amRNSCollaboration Agreement with Airbus
2nd Mar 20177:00 amRNSContract Win
28th Feb 201710:09 amRNSTotal Voting Rights
7th Feb 20177:00 amRNSEnterprise Securities Market Notice
1st Feb 20173:54 pmRNSIssue of Equity
30th Dec 201610:57 amRNSTotal Voting Rights
23rd Dec 20167:00 amRNSEnterprise Securities Market Notice
19th Dec 20164:06 pmRNSIssue of Equity
7th Dec 20161:26 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSEnterprise Securities Market Notice
1st Dec 20164:52 pmRNSIssue of Equity from exercise of Share Options
30th Nov 201612:21 pmRNSTotal Voting Rights
8th Nov 20167:00 amRNSEntry into Retail Analytics market
8th Nov 20167:00 amRNSEnterprise Securities Market Notice
3rd Nov 20164:21 pmRNSDirector/PDMR Shareholding
3rd Nov 20164:20 pmRNSDirector/PDMR Shareholding
3rd Nov 20164:19 pmRNSDirector/PDMR Shareholding
1st Nov 20166:13 pmRNSIssue of Equity
1st Nov 20167:00 amRNSHalf Yearly Report
19th Oct 20167:00 amRNSNotice of Interim Results
30th Sep 20169:53 amRNSTotal Voting Rights
14th Sep 20167:00 amRNSEnterprise Securities Market Notice
7th Sep 20162:15 pmRNSIssue of Equity from exercise of Share Options
29th Jul 20161:29 pmRNSTotal Voting Rights
20th Jul 20164:59 pmRNSDirector Shareholding - AMENDMENT
19th Jul 20165:03 pmRNSDirector Shareholding
12th Jul 20167:00 amRNSDirector/PDMR Shareholding
30th Jun 20168:05 amRNSTotal Voting Rights
23rd Jun 20162:06 pmRNSResult of AGM
15th Jun 20167:00 amRNSDirector/PDMR Shareholding
6th Jun 201612:00 pmRNSIssue of Equity from exercise of Share Options
3rd Jun 20163:45 pmRNSAnnual Report 2015/16 and AGM Notice
19th May 20165:11 pmRNSHolding(s) in Company
17th May 20167:00 amRNSFinal Results
13th May 20164:38 pmRNSDirectorate Change
27th Apr 20167:00 amRNSStrategic Partnership with Thomson Reuters
26th Apr 20167:00 amRNSNotice of Results
4th Apr 20167:00 amRNSTrading Update
31st Mar 20164:44 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.